The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales Engagement

— —

Mehrnaz Campbell

The Omni Advantage

Accelerating the Behavioural Change with Omnichannel in Pharma Sales Engagement

Mehrnaz Campbell

$54.95 $46.40

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Onyx Publishing
16 January 2024

Chemical industries; Pharmacology; Pharmaceutical technology

We’re battling Zoom fatigue. We’re burnt out. We’re a lost generation, clawing our way through endless economic permacrisis.

The pharma industry, in response, has lunged towards digital transformations and omnichannel implementations, yet very little has improved as a result. In fact, it feels as though things have only gotten worse. The COVID pandemic has a lot to answer for, and the problems pharma faced as a result of the pandemic have only been compounded by this digital transformation. Many executives and field teams have found themselves lost amidst constant reorganisations, unsure how get back to the performance levels they had before.

Enter The Omni Advantage by Mehrnaz Campbell, a beacon of clarity in this digital fog. Herein lies a vision for a future that is secure and effective. It urges leaders to rediscover the timeless currency of trust and authentic communication in a digital age.

Campbell expertly guides professionals on how they can focus on what truly matters. Specifically, she shows them how to bypass the distractions of the shiny objects and how to home in on the meaningful human connections that have always formed the industry’s cornerstone.

With insightful examples and actionable advice, you have in your hands an essential ally for the commercial, medical, and marketing leaders who want to see beyond these turbulent times. It’s a concise roadmap to rebuilding confidence, enhancing quality, and fostering genuine engagement in an industry poised for meaningful change.

Seize the advantage—the Omni Advantage!

By: Mehrnaz Campbell
Imprint: Onyx Publishing
Country of Publication: United Kingdom
Dimensions: Height: 229mm, Width: 152mm,
ISBN: 9781913206536
ISBN 10: 191320653X
Pages: 150
Publication Date: 16 January 2024
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Mehrnaz Campbell is the founder and CEO of Cheemia, a Scottish company that is managed remotely from the US. Mehrnaz has a successful track record of gaining market access and exponentially growing brands on behalf of pharma companies in the UK while assisting the NHS in achieving millions in efficiency savings and improving patient outcomes. Born in Iran, Mehrnaz relocated to the UK at the age of twenty-one to pursue higher education and her career ambitions. Her passion for learning is reflected in her academic qualifications, which encompass general nursing, a postgraduate diploma in management studies, a postgraduate diploma in marketing, and a master’s in business administration. With over thirty-seven years of experience in UK healthcare, Mehrnaz started as a nurse and transitioned to various sales and marketing leadership positions with pharmaceutical giants such as GSK, Pfizer, and Takeda. Her final role was as Multichannel Strategy Director at Takeda UK before embarking on her entrepreneurial journey by founding Cheemia in 2017. In August 2020, she introduced Cheemia ReSET, a multi-award-winning digital transformation platform developed during lockdown. This platform empowers pharma field teams to confidently utilise digital channels to deliver value to healthcare professionals (HCPs). The online training platform has not only helped global sales teams survive, but also thrive, achieving outstanding sales results, earning bonuses, advancing careers, and increasing earnings per share for pharmaceutical companies. While Mehrnaz now primarily resides in the US, her passion for supporting Scottish charities and freelancers and the local economy remains unwavering. Her entire team is based in the UK, a testament to her commitment to the country that gave her many opportunities.